Saline Flush
Othersterile saline 20 mL flushed into their catheter by trained nurses or study team members every 6 ± 2 hours
NCT Number: NCT06427538
Infections of the pleural space are common, and patients require antibiotics and chest drain placement to evacuate the chest from the infected fluid. Chest drains can get blocked by the drainage fluid and material. For this reason, it is thought that flushing the chest drain with saline solution, can help maintain the patency of the tube. This proposed study will evaluate the impact of regular chest drain flushing on the length of time to chest tube removal and total hospitalization as well as improvement in chest imaging and the need for additional interventions on the infected space.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Henry Ford, Sterling Heights, Michigan, United States
There are no randomized controlled trials (RCTs) evaluating the role of regular chest tube flushing in the setting of pleural space infection for optimal drainage and treatment outcomes. Most studies of <16 Fr catheters have used both flushing and suction to decrease the likelihood of catheter blockage and improve drainage efficiency, however, this practice has never been studied prospectively or in RCTs. Regular flushing (e.g., 20-30 ml saline every 6 h via a three-way tap) is recommended for small chest drains by the British Thoracic Society (BTS) 2010 Guidelines. This practice is followed variably by some and not used by others. Importantly, the role of this practice in successful drainage of infected fluid, and patient-centric outcomes has not been investigated. Inconsistent flushing practices confound the interpretation of therapeutic modalities (such as intrapleural tissue plasminogen activator and deoxyribonuclease therapy) success or lack thereof and limit the execution of RCTs and prospective studies of the pleural space in the setting of infection.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
sterile saline 20 mL flushed into their catheter by trained nurses or study team members every 6 ± 2 hours
Time frame: up to 3 months
The investigators will assess the time from randomization (within 24 hours of chest tube placement) until time to chest tube removal
Time frame: up to 365 days
Time frame: through study completion, an average of 3 months
Time frame: an average of 3 months
number of additional procedures through study completion
Time frame: through study completion, an average of 3 months
Contact information is provided by the study sponsor or research team.
Jennifer Duke, MD
CONTACT
Samira Shojaee, MD, MPH
CONTACT
Vanderbilt University Medical Center
Other
Acronym: RELIEF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07095361
Complicated Pleural Effusion/ Empyema, Empyema
New Haven, Connecticut, United States
View Trial DetailsNCT06657898
Abscess, Empyema
Belgrade, Serbia
View Trial DetailsNCT07137507
Empyema, Empyema, Pleural
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT06325904
Empyema, Empyema, Pleural
Minya, Egypt
View Trial Details